-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Ampulla adenocarcinoma is amalignant tumorinvolvingVater's ampulla (AoV) and duodenal papilla.
Ampullary carcinoma is an involvement ampullary carcinoma ampullary carcinomaampulla of Vater (AoV) and malignant duodenal papilla.
Cancer staging can be divided into clinical staging and pathological staging.
Recently, a study published in the journal European Radiology predicted the low survival rate and tumor recurrence of patients with ampullary adenocarcinoma by comparing preoperative clinical, CT findings and histopathological results.
This study retrospectively analyzed 216 patients with ampullary adenocarcinoma who underwent preoperative CT examination and surgical treatment.
This study retrospectively analyzed 216 patients with ampullary adenocarcinoma who underwent preoperative CT examination and surgical treatment.
The median of OS was 62.
Table 1 Clinical and histopathological characteristics predict overall survival and disease-free survival after surgery.
Table 1 Clinical and histopathological characteristics predict overall survival and disease-free survival after surgery.
Table 2 CT findings predict overall survival and disease-free survival after surgery.
Table 2 CT findings predict overall survival and disease-free survival after surgery.
Preoperative clinical and CT findings of patients with ampullary adenocarcinoma can predict their prognosis.
Original source: Original source:
Heera Yoen,Jung Hoon Kim,Bo Yun Hur,et al.
Heera Yoen,Jung Hoon Kim,Bo Yun Hur,et al.
Prediction of tumor recurrence and poor survival of ampullary adenocarcinoma using preoperative clinical and CT findings.
DOI: org/10.
1007/s00330-020-07316-4">10.
1007/s00330-020-07316-4 Heera org/10.
1007/s00330-020-07316-4">org/10.
1007/s00330-020-07316-4">Yoen ,Jung Hoon Kim,Bo Hur yun, et Al Prediction of Survival of tumor Recurrence and Poor Clinical ampullary adenocarcinomas and the using the preoperative CT findings.
DOI:.
org/10.
1007/s00330-020-07316-4">10.
1007 / s00330-020-07316-4org/10.
1007/s00330-020-07316-4"> 10.
1007 / s00330-020-07316-4 in this message
